Displaying items by tag: oneal comprehensive cancer center

These new results, led by primary author Warner Huh, M.D., strengthen the promise that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers.

This gene silencing by ubiquitinated histone is vital in normal embryo development, and it goes awry in some cancers.
An art event will be held Aug. 17 to engage the cancer community in the healing power of art.
This potential chemotherapeutic agent to treat glioblastoma — a primary brain tumor with dismal survival rates — is a novel small molecule inhibitor.
UAB is the only institution in Alabama chosen to date to participate in the TAPUR Study to help further understand targeted therapies in patients with advanced cancers.
Recent findings from an innovative nationwide trial indicate that the drug pembrolizumab, when used in combination with standard therapy, may provide positive results for patients with locally advanced breast cancer.
Michael Birrer, a leading medical oncologist at Harvard University, will take the reins as the new director of the UAB Comprehensive Cancer Center, succeeding the retiring Edward Partridge.
The UAB Cancer Center offers patients with advanced and rare cancer, including those with any stage of pancreatic and brain cancer, the opportunity to have no-cost tumor profiling, and patients may be matched with an appropriate clinical trial or recommend use of an FDA-approved drug.
The annual symposium May 15 will provide help and support for cancer patients and survivors.
The University of Alabama at Birmingham announces a partnership with Guideway Care to expand the reach of UAB’s proven cancer navigation program, Patient Care Connect, to patients nationally.
A new pilot investigation at UAB is rethinking the exercise paradigm for breast cancer survivors with reduced mobility, evaluating the utility of simulated high-altitude training for the purpose of enhancing health and physical activity.
UAB Comprehensive Cancer Center’s Fiesta Ball on May 5 will support the work of young cancer research scientists and patient and family services.
Coalesce, a new support group for young adult cancer survivors, kicks off with a drum circle event at Railroad Park on April 15.

Unusual case of teen patient diagnosed with colorectal cancer receives innovative first-in-human clinical trial at UAB, reflecting a unique story of cancer and hope.

Cycliad, a community cycling event, will be held March 25 in Birmingham to benefit cancer patients at UAB.
Failure of hormone deprivation therapy used to slow prostate cancer in patients leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatment options. Endostatin, used in combination therapy, may help delay onset of castration-resistant disease.
Page 20 of 33